Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Miaoling Li has a total of 118 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Restoring myocardial sodium–calcium homeostasis: A central mechanism of empagliflozin in heart failure

    by Jian Lu, Yunru Wang, Wenyue Zheng, Min Zhang, Cheng Pu, Yujie Luo, Xinrong Fan, Changzheng Gao, Miaoling Li

  • Unraveling Sex Disparities of Atrial Fibrillation/Flutter in Asia: Contributions of Lifestyle Factors (Smoking, Excessive Alcohol Intake) and Life Expectancy

    by Yurun Shi, Fanxi Xiong, Dan Li, Yue Zhou, Jian Lu, Wenyue Zheng, Yunru Wang, Wenjun Huang, Lin Wu, Miaoling Li

    Background: The burden of atrial fibrillation/atrial flutter (AF/AFL) continues to increase globally, particularly in rapidly ageing regions such as Asia. However, the contributions of population aging, life expectancy, and lifestyle‐related risk factors to sex‐specific disparities in AF/AFL burden remain poorly understood. Objectives: To investigate sex‐specific differences in AF/AFL burden across Asia and evaluate the contributions of population ageing, life expectancy, and modifiable risk factors using Global Burden of Disease (GBD) data. Methods and Results: GBD data were used to assess AF/AFL prevalence, incidence, disability‐adjusted life years (DALYs), mortality, and attributable risk factors across 34 Asian countries and regions, stratified by sex and age. In 2023, AF/AFL affected 59.10 million individuals worldwide, with Asia accounting for nearly half of the global burden. Prevalence and incidence were consistently higher in males, whereas females, particularly at older ages, experienced a greater burden of DALYs and mortality. Marked heterogeneity was observed across Asian countries. Population ageing emerged as a major driver of AF/AFL burden, with most Asian countries classified as aging or aged societies. Hypertension was the leading attributable risk factor overall, while smoking and excessive alcohol consumption contributed disproportionately to the male burden. Forecasting analyzes projected a continued increase in AF/AFL burden through 2036. Conclusion: AF/AFL remains a growing public health challenge across Asia. Although prevalence is higher in males, elderly females bear a disproportionately greater burden of disability and mortality. Population ageing, together with smoking and excessive alcohol consumption in men, may contribute substantially to these sex disparities. Sex‐ and age‐specific prevention and management strategies are needed to reduce the future burden of AF/AFL in Asia.

  • Open Access

    Calpain inhibition preserves myofilament integrity and prevents vandetanib–induced cardiac dysfunction

    by Fang Ji, Jie Huang, Jie Yan, Si Lv, Lin Lu, Hu Wen, Jian Lu, Huan Yuan, Yinshan Gu, Bin Liao, et al.


  • Open Access

    Impact of percutaneous coronary intervention with different guidance modalities in patients with coronary artery lesions: a network meta-analysis and systematic review

    by Tao Jiang, Jie Huang, Lisha Luo, Miaoling Li, Gong Chen

    Background: Traditional coronary angiography has inherent limitations in terms of lesion assessment and stenting. New guidance modalities to guide percutaneous coronary intervention (PCI) are now available.Methods: We systematically searched PubMed, Embase, Cochrane, and Web of Science databases for the period from the time of construction to 25 April 2024. A network meta-analysis of randomized controlled trials (RCT) was performed to determine the optimal treatment strategy by comparing the short-term outcome and long-term prognosis of adverse cardiovascular outcomes in patients with coronary artery lesions after eight different PCI-guided modalities. The clinical outcomes included major adverse cardiovascular events (MACE), all-cause mortality, cardiac death, myocardial infarction, and target vessel revascularization (TVR). Risk ratios (RR) with 95% confidence intervals (CI) were calculated.Results: Forty randomized controlled trials with a total of 38,107 patients were included. In the MACE subgroup up to 12 months, Intravascular Ultrasound-guided Percutaneous Coronary Intervention (IVUS-PCI) [RR = 1.60, 95%CI = (1.10, 2.30)], Optical Frequency Domain Imaging-guided Percutaneous Coronary Intervention (OFDI-PCI) [RR = 2.36, 95%CI = (1.05, 5.80)] and Quantitative Flow Ratio-guided Percutaneous Coronary Intervention (QFR-PCI) [RR = 1.45, 95%CI = (1.15, 1.83)] significantly reduced the incidence of MACE. In the MACE subgroup at 12 months, Fractional Flow Reserve-guided Percutaneous Coronary Intervention (FFR-PCI) [RR = 0.72, 95%CI = (0.49, 0.99)], IVUS-PCI [RR = 0.66, 95%CI = (0.43, 0.99)] and Optical Coherence Tomography-guided Percutaneous Coronary Intervention [RR = 0.59, 95%CI = (0.35, 0.92)] all significantly reduced the incidence of MACE in patients. FFR-PCI [RR = 0.42, 95%CI = (0.20, 0.75)] significantly reduced the incidence of cardiac death in patients compared to Angiography-guided Percutaneous Coronary Intervention (Angio-PCI). FFR-PCI [RR = 0.78, 95%CI = (0.62, 0.99)], OCT-PCI [RR = 0.59, 95%CI = (0.35, 0.97)], QFR-PCI [RR = 0.64, 95%CI = (0.45, 0.91)] were associated with a lower risk of myocardial infarction compared to Angio-PCI. The incidence of Target Vessel Revascularization (TVR) was significantly lower in patients who underwent IVUS-PCI [RR = 0.57, 95%CI = (0.36, 0.86)], OCT-PCI [RR = 0.47, 95%CI = (0.24, 0.95)] than in those who underwent Angio-PCI. However, there were no significant differences between the different guidance modalities and subgroup analyses in improving overall survival.Conclusion: IVUS and OCT were more effective in reducing MACE and TVR. This suggests that IVUS and OCT may be the best strategies in the interventional management of complex coronary lesions.Systematic Review Registration: PROSPERO CRD42024567598.


  • Open Access

    Multimodal imaging in diagnosing a giant isolated fibrotic right ventricular diverticulum

    by Shengzhong Liu, Lili Zou, Fangfang Yu, Miaoling Li

  • The Association between Serum Lipid Profile Levels and Hypertension Grades: A Cross-Sectional Study at a Health Examination Center

    by Ling Huang, Zhangyi Liu, Huayang Zhang, Dan Li, Zhiyi Li, Jie Huang, Jie He, Lin Lu, Hu Wen, Huan Yuan, et al.

    Introduction Hypertension and dyslipidemia are major cardiovascular risk factors that often coexist. Hyperlipidemia is a crucial modifiable risk factor in preventing cardiovascular disease. Aim We aimed to explore the relationship between lipid levels and the grading of hypertension in a community-based adult population. Methods A total of 63,091 non-employed individuals were included in this study. Measurements included systolic blood pressure (SBP), diastolic blood pressure (DBP), body mass index (BMI), fasting plasma glucose (FPG), alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (STB), serum creatinine (SCr), blood urea nitrogen (BUN), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-c), and high-density lipoprotein cholesterol (HDL-c). Chi-square and t-tests were used to obtain basic population characteristics. Multivariate logistic regression was used to evaluate the association between the prevalence of hypertension and lipid profiles, as well as to identify influencing factors. A P-value < 0.05 was considered statistically significant. Statistical charts were utilized to analyze the relationship between lipid parameters and hypertension grades. Results A total of 30,588 men and 32,503 women with an average age of 64.57 ± 12.5 years participated in this study. After adjusting STB and TC, every 1 mmol/L increase in TG and LDL-c was associated with a 6.0% and 6.5% increase in the prevalence of hypertension, respectively. Conversely, for every 1 mmol/L increase in HDL-c, the prevalence of hypertension decreased by 4.1%. Increases in TG and LDL-c levels were observed across all grades of hypertension, while very high HDL-c was significantly associated in grade III hypertension (1.54→1.66 mmol/L). Additionally, age, BMI, FPG, ALT, AST, SCr, and BUN significantly influenced the association between hypertension and lipid levels. Conclusion Hyperlipidemia and hypertension often coexist in health examination populations. Elevated levels of TG and LDL-C are associated with all grades of hypertension, while extremely high HDL-C level is linked to more severe hypertension. Graphical Abstract


  • Exploring Cutting-Edge Approaches to Potentiate Mesenchymal Stem Cell and Exosome Therapy for Myocardial Infarction

    by Chendong Peng, Jie Yan, Yu’aNg Jiang, Lin Wu, Miaoling Li, Xinrong Fan

    Cardiovascular diseases (CVDs) continue to be a significant global health concern. Many studies have reported promising outcomes from using MSCs and their secreted exosomes in managing various cardiovascular-related diseases like myocardial infarction (MI). MSCs and exosomes have demonstrated considerable potential in promoting regeneration and neovascularization, as well as exerting beneficial effects against apoptosis, remodeling, and inflammation in cases of myocardial infarction. Nonetheless, ensuring the durability and effectiveness of MSCs and exosomes following in vivo transplantation remains a significant concern. Recently, novel methods have emerged to improve their effectiveness and robustness, such as employing preconditioning statuses, modifying MSC and their exosomes, targeted drug delivery with exosomes, biomaterials, and combination therapy. Herein, we summarize the novel approaches that intensify the therapeutic application of MSC and their derived exosomes in treating MI. Graphical abstract


  • Acacetin Alleviates Cardiac Fibrosis via TGF-β1/Smad and AKT/mTOR Signal Pathways in Spontaneous Hypertensive Rats

    by Zhi-Yi Li, Si Lv, Jie Qiao, Si-Qi Wang, Fang Ji, Dan Li, Jie Yan, Yan Wei, Lin Wu, Changzhen Gao, et al.

    Introduction: Attenuating cardiac fibroblasts activation contributes to reducing excessive extracellular matrix deposition and cardiac structural remodeling in hypertensive hearts. Acacetin plays a protective role in doxorubicin-induced cardiomyopathy and ischemia/reperfusion injury. The aim of this study was to investigate the potential molecular mechanisms underlying the protective role of acacetin on hypertension-induced cardiac fibrosis. Methods: Echocardiography, histopathological methods, and Western blotting techniques were used to evaluate the anti-fibrosis effects in spontaneous hypertensive rat (SHR) which were daily intragastrically administrated with acacetin (10 mg/kg and 20 mg/kg) for 6 weeks. Angiotensin II (Ang II) was used to induce cellular fibrosis in human cardiac fibroblasts (HCFs) in the absence and presence of acacetin treatment for 48 h. Results: Acacetin significantly alleviated hypertension-induced increase in left ventricular (LV) posterior wall thickness and LV mass index in SHR. The expressions of collagen-1, collagen-III, and alpha-smooth muscle actin (α-SMA) were remarkedly decreased after treatment with acacetin (n = 6, p < 0.05). In cultured HCFs, acacetin significantly attenuated Ang II-induced migration and proliferation (n = 6, p < 0.05). Moreover, acacetin substantially inhibited Ang II-induced upregulation of collagen-1 and collagen-III (n = 6, p < 0.05) and downregulated the expression of alpha-SMA in HCFs. Additionally, acacetin decreased the expression of TGF-β1, p-Smad3/Smad3, and p-AKT and p-mTOR but increased the expression of Smad7 (n = 6, p < 0.05). Further studies found that acacetin inhibited TGF-β1 agonist SRI and AKT agonist SC79 caused fibrotic effect. Conclusion: Acacetin inhibits the hypertension-associated cardiac fibrotic processes through regulating TGF-β/Smad3, AKT/mTOR signal transduction pathways.